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Abstract
The first metabolite of alcohol, acetaldehyde, may trigger replication errors and mutations in DNA, which may predispose to developing
colorectal cancer (CRC). In a prospective study on colon and rectal cancer, we investigated the following hypotheses: alcohol consumption
is associated with an increased risk of mutations in the K-ras oncogene, and beer consumption is associated with an increased risk of G/
A mutations in this gene. Therefore, we studied the associations between consumption of alcohol and alcoholic beverages and the risk of
CRC without and with specific K-ras gene mutations. In 1986, 120,852 men and women, aged 55e69 years, completed a questionnaire on
risk factors for cancer. The caseecohort approach was used for data processing and analyses. After 7.3 years of follow-up, excluding the
first 2.3 years, complete data from 4,076 subcohort members, 428 colon and 150 rectal cancer patients, were available for data analyses.
Incidence rate ratios (RRs) and corresponding 95% confidence intervals (95% CIs) were estimated using Cox proportional hazards models.
Compared to abstaining, a total alcohol consumption of 30.0 g/day and more was associated with the risk of colon and rectal cancer with
and without a K-ras mutation in both men and women. Independent from alcohol intake, liquor consumption when compared to nonliquor
consumption was associated with an increased risk of rectal cancer with a wild type K-ras in men (RR: 2.25, 95% CI: 1.0e5.0). Beer con-
sumption was not clearly associated with the risk of colon and rectal tumors harboring G/A mutations in the K-ras gene in men. This
association could not be assessed in women because of sparse beer consumption. In conclusion, alcohol does not seem to be involved in
predisposing to CRC through mutations in the K-ras gene, and specifically beer consumption is not associated with colon and rectal tumors
harboring a G/A mutation.  2006 Elsevier Inc. All rights reserved.
Keywords: Alcohol; Colorectal cancer; K-ras mutations; Cohort study; The Netherlands1. Introduction
Consumption of alcohol is well-known to be associated
with several malignant and nonmalignant diseases. Al-
though alcohol itself is not carcinogenic, there is increasing
evidence that acetaldehyde, a cytotoxic, mutagenic, and
carcinogenic metabolite of alcohol, rather than alcohol it-
self, is responsible for tumor enhancing effects (Salaspuro,
2003; Seitz et al., 2001). Acetaldehyde can bind to cellular
proteins and DNA, and the additional formation of stable
DNA adducts could trigger replication errors and mutations
in tumor suppressor genes or oncogenes. Acetaldehyde may
also interfere with DNA repair by inhibiting enzymes
* Corresponding author. Tel.: þ31-43-3882236; fax: þ31-43-3884128.
E-mail address: Brenda.Bongaerts@epid.unimaas.nl (B.W.C.
Bongaerts).0741-8329/06/$ e see front matter  2006 Elsevier Inc. All rights reserved.
doi: 10.1016/j.alcohol.2006.06.003important to the repair of adducts caused by alkylating
agents (Ahmed, 1995; Salaspuro, 2003; Seitz et al.,
2001). Regarding these mechanisms, it is plausible to
consider alcohol consumption as a possible risk factor for
developing colorectal cancer (CRC).
Development of CRC is a multistep process, character-
ized by an accumulation of several genetic alterations driv-
ing normal colorectal mucosa to transform into highly
malignant derivatives (Fearon & Vogelstein, 1990; Vogel-
stein et al., 1988). An early event in colorectal tumorigen-
esis is often an activating mutation in the K-ras oncogene.
K-ras mutations occur in 30e60% of colorectal carcinomas
and are involved in the progression of small adenomas to
the more clinically relevant larger adenomas. Therefore,
K-ras mutations may be an important contributor to CRC
development. Most K-ras mutations are G/A transitions
and G/ T transversions (Brink et al., 2003; Fearon &
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with these types of K-ras point mutations have a poor prog-
nosis and a high risk of recurrence of the disease (Cerottini
et al., 1998; Span et al., 1996). Knowledge of the etiology
of K-rasmutations arising in colorectal tumors may provide
valuable clues for prevention strategies.
The association between alcohol consumption and CRC
was long debated, and according to a recently published
pooled analysis of eight prospective cohort studies, CRC
risk is only increased when daily alcohol consumption
levels exceed 30.0 g (Cho et al., 2004). This suggests that
there may be a threshold in alcohol consumption above
which the risk of CRC is increased. The role of different
types of alcoholic beverages on the risk of CRC is less
clear, although beer consumption has more consistently
been implicated in the etiology of rectal cancer. In the past,
beer in the Netherlands and in other European countries
was contaminated with relatively large amounts of N-nitro-
sodimethylamine (NDMA) (mean 1.2 mg/kg) (Spiegelhald-
er et al., 1979; Stephany & Schuller, 1980). As such, beer
drinking accounted for 90% of the NDMA intake in beer
drinkers, whose total NDMA intake was as much as 10
times higher than that of nonbeer drinkers. Jacoby et al.
(1992) have shown that nitrosamines have mutagenic prop-
erties and are able to induce mutations, especially G/A
transitions in the K-ras gene in rodents. However, since
1979, changes in the beer-brewing process have greatly de-
creased the NDMA contaminations in beers (Ellen &
Schuller, 1983). Yet it is likely that the adverse effects of
NDMA still influences the risk of (rectal) cancer for up to
10 years later, and that this declines in the years thereafter.
Taking into account the mutagenic and carcinogenic po-
tentials of acetaldehyde mentioned above, we hypothesized
that alcohol consumption is associated with an increased
risk of mutations in the K-ras oncogene involved in CRC.
Hence, we examined the associations between consumption
of alcohol and various alcoholic beverages and the risk of
colon and rectal cancer with and without K-ras gene muta-
tions. In a second hypothesis, we stated that beer consump-
tion is associated with G/A mutations in the K-ras gene
involved in CRC. To answer this hypothesis, we examined
the associations between beer consumption and this specific
type of K-ras mutation among the colon and rectal cancer
cases in our study population.
2. Materials and methods
2.1. Study population
In September 1986, the Netherlands Cohort Study on diet
and cancerwas initiated. The study design has been described
in detail elsewhere (Van denBrandt et al., 1990a). Briefly, the
cohort included 58,279men and 62,573 women, aged 55e69
years at baseline and originating from 204municipal popula-
tion registries throughout the country. All cohort members
completed an extensive self-administered questionnaire ondaily dietary habits during the year preceding the start of
the study, lifestyle factors, and other risk factors for cancer.
Newly diagnosed cancer cases in the entire cohort were iden-
tified through annual record linkage to the Netherlands Can-
cer Registry (NCR, comprising nine cancer registries in the
Netherlands) and to the Netherlands nationwide registry of
pathology (PALGA), a nationwide database of histo- and
cytopathology reports, used for identification and location
of tumor tissue from eligible CRC cases stored in 54 Dutch
Pathology laboratories (Van den Brandt et al., 1990b).
These analyses were carried out over the 7.3-year period
of follow-up since September 1986. The first 2.3 years of
follow-up were excluded, due to incomplete coverage of
PALGA in some of the municipalities included and since
subclinical symptoms may have influenced the exposure sta-
tus in cases diagnosed during these 2.3 years. Using updated
information from the NCR in 2004, 925 cases with histolog-
ically confirmed CRC were identified with an incidence date
between January 1989 and January 1994, of whom 815 could
be linked to a PALGA report of the lesion. CRC was classi-
fied according to site as follows, colon: cecum through sig-
moid colon (ICD-O codes 153.0, 153.1, 153.2, 153.3, 153.4,
153.5, 153.6, 153.7, 153.8, 153.9); rectosigmoid colon
(ICD-O code 154.0); and rectum (ICD-O code 154.1).
Processing and analysis of data were done according to
the caseecohort approach: cases were identified for the en-
tire cohort, whereas a random sample of the cohort (subco-
hort) was used to estimate person years at risk accumulating
in the cohort (from the date of entry into the cohort until the
date of a CRC diagnosis, death from any cause, leaving the
study area, or the end of the 7.3-year follow-up period).
This subcohort of 5,000 men and women was followed-
up biennially to assess information on vital status and mi-
gration to calculate accumulated person time in the cohort.
Prevalent cancer cases, other than nonmelanoma skin can-
cer were excluded from the subcohort, resulting in 4,748
subcohort members. During the first 2.3 years of follow-
up, 101 (2%) subcohort members deceased or were diag-
nosed with cancer other than nonmelanoma skin cancer,
leaving 4,647 subcohort members for analysis.
2.2. Assessment of exposure
Information on daily dietary habits was obtained by
a 150-item semiquantitative food frequency questionnaire.
Alcohol consumption was measured by six items: (1) beer,
(2) red wine, (3) white wine, (4) sherry and other fortified
wines, (5) liqueur (containing 16% alcohol), and (6)
(Dutch) gin, brandy, and whiskey, which are presumed to
cover all types of consumed alcoholic beverages. Partici-
pants were asked about their usual frequency of consump-
tion (never/less than once per month, once per month,
2e3 times per month, once per week, 2e3 times per week,
4e5 times per week, and 6e7 times per week) and the
number of glasses consumed at each drinking occasion.
The total amount of alcohol per day (g/day) was calculated
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consumed, and the alcohol content of the consumedbeverage.
The questionnaire has been validated against a 9-day diet
record (Van den Brandt et al., 1990a). The Spearman corre-
lation coefficient between mean daily alcohol intake as-
sessed by the questionnaire and estimated from the 9-day
diet record was 0.89 for all subjects and 0.85 for users of al-
coholic beverages. The absolute amount of alcohol reported
in the questionnaire by users of alcoholic beverages was, on
average, 86% of that reported in the 9-day diet record.
Next to the dietary section, the questionnaire comprised
a section on lifestyle and other risk factors for cancer. Infor-
mation on, for instance, family history of CRC, sex, age at
baseline, smoking, and body mass index (BMI) were
retrieved from this section.
2.3. Tissue samples and molecular analyses
Tumor material of CRC cases, identified in the entire co-
hort, was collected after approval of the Ethical Review
Boards of University Maastricht, the NCR and PALGA.
From 44 (5%) of the eligible 815 CRC cases, tissue samples
could not be retrieved. Of the retrieved 771 tissue samples,
37 (5%) contained only healthy colorectal mucosa, did not
yield sufficient DNA for molecular analyses, or were
revised as a benign adenoma instead of a carcinoma by a
pathologist. Hence, tumor tissue of 734 CRC cases was
available for molecular analyses.
Mutation analysis of the exon 1 fragment of the K-ras
oncogene, spanning codons 8e29, was performed on ar-
chived adenocarcinoma specimens of all 734 CRC patients
(Brink et al., 2003).
2.4. Data analyses
Data analyses were based on subcohort members and
cases for whom information on alcohol consumption and
confounding variables were complete, i.e., 4,076 subcohort
members, 428 colon cancer cases, and 150 rectal cancer
cases. Since the rectosigmoid can be considered as a clini-
cally applied term rather than an anatomically defined tran-
sitional zone between the colon and the rectum, cases with
a rectosigmoid tumor (n5 70) were excluded from data
analyses. Moreover, the group of cases with a rectosigmoid
tumor was too small for adequate stratified analyses. Inci-
dence rate ratios (RRs) and corresponding 95% confidence
intervals (CIs) were estimated using Cox proportional haz-
ards models. The proportional hazards assumption was
tested using the scaled Schoenfeld residuals (Schoenfeld,
1982). Standard errors were estimated using the robust Hu-
bereWhite sandwich estimator to account for additional
variance introduced by sampling from the cohort.
Next to considering total amount of alcohol consump-
tion, we examined three types of alcoholic beverages, i.e.,
beer, wine (red wine, white wine, sherry, and other fortified
wines), and liquor (liqueur, gin, brandy, and whiskey). An
extensive categorization of the alcohol variables was notpossible due to small numbers of cases per category. Only
total alcohol consumption was divided into three cate-
gories: 0, !30.0, and $30.0 g/day. The threshold value
of 30.0 g/day was chosen in line with the results of the
pooled analysis by Cho et al. (2004).
Data analysis was conducted separately for male and fe-
male colon and rectal cancer with and without a K-ras mu-
tation, described here as K-rasþ (tumors harboring a K-ras
mutation) and K-ras (tumors harboring a wild type K-ras
gene). However, since several cells comprised less than 10
cancer cases and some reference groups comprised rela-
tively small numbers of cases, analyses were also con-
ducted for all male plus female CRC cases with and
without a K-ras mutation. In the overall analyses only,
the rectosigmoid cancer cases were included.
In the light of our second hypothesis, cases with a K-ras
mutation were further examined for associations between
beer consumption and the risk of colon and rectal cancer
harboring a G/A mutation in the K-ras gene.
Age at baseline (years), BMI (kg/m2), family history of
CRC (yes vs. no), daily intake of total energy (kJ/day),
daily folate intake (mg/day), daily intake of linoleic acid
(g/day) and calcium (mg/day), physical activity (min/
day), and smoking (never, ex, current) were considered as
potential confounders. Those variables that changed the re-
gression coefficient for alcohol by more than 10%, or those
that were found to statistically significantly contribute to
the multivariable model for colon and rectal cancer were in-
cluded in the analyses. Analyses for beer, wine, and liquor
were additionally adjusted for total alcohol consumption
(as a categorical variable), to evaluate the effect of the bev-
erage on the risk of colon and rectal cancer independent of
the beverage’s alcoholic content. Interactions between sex
and alcohol consumption were investigated as well as inter-
actions between smoking and alcohol, and folate intake and
alcohol, but none of the tested interactions were found to be
statistically significant. P-values!.05 were considered sta-
tistically significant. All analyses were performed with the
STATA statistical software package.
3. Results
Alcohol intake and baseline characteristics of the study
population are presented in Table 1. Overall, both male
and female colon and rectal cancer patients tended to be
older in age than subcohort members. For female colon
cancer cases, cases with a K-rasþ tumor were older in
age than cases with a K-ras tumor (P! .05). Further-
more, for both men and women, there were no significant
differences in alcohol consumption or lifestyle characteris-
tics when comparing the K-ras colon tumors with the K-
rasþ colon tumors or when comparing the K-ras rectal
tumors with the K-rasþ rectal tumors.
Associations between drinking habits in men and the
risk of K-ras and K-rasþ colon and rectal tumors are pre-
sented in Table 2. Consumption equal to or exceeding
Table 1
Baseline charact etherlands Cohort Study (1986e1993)
en
ohort
Colon cancer Rectal cancer
Wild type K-ras Mutated K-ras Wild type K-ras Mutated K-ras
N 140 58 24 27
Age (years) (4.3) 62.7 (4.3)a 64.0 (3.5) 63.5 (3.7) 61.5 (3.7)
Alcohol consum
Total alcohol .4) 6.0 (12.5) 4.1 (7.1) 5.3 (6.5) 6.9 (3.7)
Beer (glasses/ .5) 0.3 (2.0) 0.04 (0.2) 0.1 (0.7) 0.1 (0.3)
Wine (glasses/ .8) 2.5 (5.2) 1.7 (3.5) 2.9 (4.1) 3.4 (6.4)
Liquor (glasse .8) 1.1 (4.4) 1.0 (2.5) 0.4 (1.1) 0.9 (2.1)
Total alcohol (%
Abstainers 37 46 38 26
0.1e4.9 g/day 35 28 21 41
5.0e14.9 g/da 13 15 33 18
15.0e29.9 g/d 9 9 8 11
$30.0 g/day 6 2 0 4
Other characteris
Family history 12.9 6.9 16.7 7.4
Body mass ind (3.6) 25.6 (3.7) 25.5 (3.7) 25.0 (3.7) 25.9 (3.1)
Calcium intak 268) 899 (256) 913 (254) 1,005 (342) 860 (214)
Linoleic acid (6.2) 11.9 (5.9) 13.6 (6.6) 11.4 (5.2) 11.4 (5.3)
Smoking (%)
Never 62 74 67 56
Exsmoker 24 16 8 33
Current smoke 14 10 25 11
aP! .05, for
bAdjusted fo
cAdjusted for
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4eristics and drinking habits (mean [S.D.]) of the study population by sex, tumor site, and K-ras status, the N
Men Wom
Subcohort
Colon cancer Rectal cancer
SubcWild type K-ras Mutated K-ras Wild type K-ras Mutated K-ras
2,029 148 82 63 36 2,047
61.3 (4.2) 62.5 (4.2) 63.4 (4.2) 62.4 (4.1) 62.3 (4.0) 61.4
ption
(g/day) 15.0 (16.8) 15.6 (16.5) 15.7 (16.3) 17.4 (19.7) 14.7 (12.7) 5.8 (9
week) 3.2 (7.1) 3.1 (7.2) 2.3 (4.3) 3.3 (6.3) 3.1 (4.7) 0.2 (1
week) 2.5 (5.2) 2.7 (4.9) 3.1 (6.1) 2.4 (5.7) 2.9 (4.6) 2.7 (4
s/week) 4.1 (6.4) 4.3 (6.5) 4.5 (6.4) 5.8 (8.7) 3.7 (4.9) 0.9 (2
)
14 15 16 11 11 33
21 24 23 25 22 36
y 27 22 20 21 17 19
ay 23 22 23 21 36 9
15 17 18 22 14 3
tics:
of CRC (%) 5.5 12.8 12.2 7.9 16.7 6.1
ex (kg/m2) 25.0 (2.6) 25.3 (2.6) 25.9 (3.1) 12.9 (2.5) 25.1 (2.7) 25.0
e (mg)b 947 (293) 976 (3,001) 930 (277) 933 (214) 843 (227) 903 (
intake (g)c 16.2 (8.2) 16.7 (7.7) 18.3 (7.8) 17.1 (8.4) 17.0 (9.1) 12.7
13 11 11 19 14 58
52 63 67 59 53 21
r 35 26 22 32 33 21
comparisons between cases without and with a K-ras mutation.
r energy intake from dairy products.
total energy intake.
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RRsa for male colon and rectal cancer cases with a wild type or a mutated K-ras gene according to drinking habits, adjusted for confounders,
the Netherlands Cohort Study (1986e1993)
Drinking habits
Person years
in subcohort
Colon cancer Rectal cancer
Wild type K-ras Mutated K-ras Wild type K-ras Mutated K-ras
Number
of cases RR (95% CI)a
Number
of cases RR (95% CI)a
Number
of cases RR (95% CI)a
Number
of cases RR (95% CI)a
Total alcohol (g/day)
No alcohol 2,035 22 1.00 13 1.00 7 1.00 4 1.00
!30.0 10,190 100 0.95 (0.6e1.6) 54 0.84 (0.4e1.6) 42 1.23 (0.5e2.8) 27 1.30 (0.4e4.0)
$30.0 2,121 26 1.24 (0.7e2.3) 15 1.15 (0.5e2.6) 14 2.00 (0.8e5.3) 5 0.98 (0.2e4.0)
Beerb
No beer 6,082 69 1.00 40 1.00 30 1.00 14 1.00
Beer drinker 8,264 79 0.84 (0.6e1.2) 42 0.78 (0.5e1.3) 33 0.68 (0.4e1.2) 22 1.09 (0.5e2.4)
Wineb
No wine 7,094 69 1.00 43 1.00 32 1.00 18 1.00
Wine drinker 7,252 79 1.11 (0.7e1.7) 39 0.85 (0.5e1.4) 31 0.79 (0.4e1.4) 18 0.92 (0.4e1.9)
Liquorb
No liquor 5,234 51 1.00 29 1.00 14 1.00 11 1.00
Liquor drinker 9,112 97 1.08 (0.7e1.7) 53 0.97 (0.5e1.7) 49 2.25 (1.0e5.0) 25 1.15 (0.5e2.7)
RR5 incidence risk ratio; CI5Confidence interval.
aAdjusted for age, family history of colorectal cancer (yes/no), body mass index (kg/m2), calcium intake (mg/day), linoleic intake (g/day), and smoking
(never/ex/current).
bAdditionally adjusted for total alcohol consumption (0, !30.0, $30.0 g/day).30.0 g of alcohol per day, compared to abstaining was asso-
ciated with an increased risk of colon cancer with and with-
out a K-ras mutation, although none of these results
reached statistical significance. For rectal cancer, both with
and without K-ras mutations, the reference group and the
group of cases who consumed 30.0 g of alcohol per day
or more was very small, making it difficult to interpret
the results correctly. Most of the associations with the dif-
ferent beverage types adjusted for total alcohol consump-
tion were not consistent, suggesting that in general no
clear associations with K-ras and K-rasþ colon and rectal
tumors existed. Compared to nonliquor consumers, liquor
consumption was associated with an increased risk of
a K-ras rectal tumor, independent of the consumed alco-
hol (RR: 2.25, 95% CI: 1.0e5.0).
Table 3 shows the associations between drinking habits
in women and the risk of K-ras and K-rasþ colon and
rectal tumors. When compared to abstaining, consumption
of 30.0 g of alcohol per day and more was positively asso-
ciated with K-ras colon tumors. The K-rasþ colon cancer
subgroup and both rectal cancer subgroups comprised too
few cases to adequately interpret the results for total alco-
hol consumption. The results for the different beverage
types independent of alcohol content, suggested that there
were no clear associations with the risk of colon and rectal
cancer with and without a K-ras mutation.
For the overall analyses (Table 4), combining all male
plus female CRC cases (including rectosigmoid cancer
cases), results pointed in the same direction as the results
for the stratified analyses presented in Tables 2 and 3. Com-
pared to abstainers, an increased risk was observed for K-
ras and K-rasþ colorectal tumors for cases whose dailyconsumption exceeded 30.0 g of alcohol. Independent of
consumed alcohol, only liquor consumption was positively
associated with the risk of K-ras colorectal tumors,
although statistical significance was not reached (RR:
1.22, 95% CI: 0.9e1.6).
To examine the hypothesis that beer consumption is asso-
ciated with G/A mutations in the K-ras gene, a further
distinction of K-rasþ tumors was made into tumors with
a G/A transition (results not shown). There were 41 male
and 29 female colon cancer cases with a G/A transition
and 20 male and 9 female rectal cancer cases harboring this
transition. When compared to the nonbeer drinkers, con-
sumption of beer was not associated with the risk of colon tu-
mors harboring a G/A mutation in men, independent of
the alcohol consumed. A positive association however was
observed between beer drinking, independent of the alcohol
consumed, and the risk of rectal tumors harboring a G/A
mutation (RR: 3.48, 95% CI: 1.1e11.0). In women, these as-
sociations could not be assessed since therewere only two fe-
male colon cancer cases and no female rectal cancer cases
harboring a G/A mutation that consumed beer.
Next to beer intake, we also considered associations be-
tween total alcohol, wine, and liquor consumption and risk
of colon and rectal tumors harboring G/A mutations, but
no significant relationships were found.
4. Discussion
4.1. Alcohol, CRC, and K-ras gene mutations
In the current prospective study, we have investigated
associations between alcohol consumption and the risk of
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RRsa for female colon and rectal cancer cases with a wild type or a mutated K-ras gene according to drinking habits, adjusted for confounders,
the Netherlands Cohort Study (1986e1993)
Drinking habits
Person years
in subcohort
Colon cancer Rectal cancer
Wild type K-ras Mutated K-ras Wild type K-ras Mutated K-ras
Number
of cases RR (95% CI)a
Number
of cases RR (95% CI)a
Number
of cases RR (95% CI)a
Number
of cases RR (95% CI)a
Total alcohol (g/day)
No alcohol 4,727 52 1.00 27 1.00 9 1.00 7 1.00
!30.0 9,467 80 0.78 (0.5e1.1) 30 0.62 (0.4e1.1) 15 0.98 (0.4e2.2) 19 1.28 (0.5e3.2)
$30.0 503 8 1.83 (0.8e4.1) 1 0.65 (0.1e5.5) 0 d 1 1.25 (0.1e11.7)
Beerb
No beer 13,239 129 1.00 55 1.00 22 1.00 24 1.00
Beer drinker 1,458 11 0.74 (0.4e1.5) 3 0.80 (0.2e2.8) 2 1.22 (0.3e6.0) 3 0.88 (0.2e3.4)
Wineb
No wine 6,507 71 1.00 33 1.00 10 1.00 11 1.00
Wine drinker 8,190 69 0.79 (0.5e1.3) 25 1.05 (0.4e2.6) 14 3.80 (0.5e30.0) 16 0.88 (0.3e2.8)
Liquorb
No liquor 9,649 90 1.00 40 1.00 18 1.00 14 1.00
Liquor drinker 5,048 50 1.16 (0.7e1.8) 18 1.20 (0.6e2.5) 6 0.56 (0.2e1.7) 13 1.72 (0.7e4.4)
RR5 incidence risk ratio; CI5 confidence interval.
aAdjusted for age, family history of colorectal cancer (yes/no), body mass index (kg/m2), calcium intake (mg/day), linoleic intake (g/day), and smoking
(never/ex/current).
bAdditionally adjusted for total alcohol consumption (0, !30.0, $30.0 g/day).colon and rectal cancer with and without K-ras mutations,
as our hypothesis implied a relationship between alcohol
consumption and colorectal tumors harboring a K-ras mu-
tation. When considering all male plus female colorectal tu-
mors according to K-ras mutational status, our results
showed that a daily alcohol consumption of 30.0 g/day
and more was associated with an increased risk of CRC,
which is consistent with current literature (Cho et al.,
2004). However, in contradiction with our hypothesis thisincrease in risk was independent of the presence or absence
of K-ras mutations. When stratifying by sex and tumor site,
this result was still observed for subgroups with sufficient
numbers of cases. No clear associations were seen between
alcohol intakes below 30.0 g/day and the risk of K-ras
and K-rasþ colon and rectal tumors in both men and
women. There is evidence that acetaldehyde is directly in-
volved in CRC (Taylor & Rehm, 2005), but also other
mechanisms have been linked to colorectal tumorigenesis,Table 4
RRsa for male and female CRC cases (including the rectosigmoid cancer cases) with a wild type or a mutated K-ras gene according
to drinking habits, adjusted for confounders, the Netherlands Cohort Study (1986e1993)
Drinking habits
Person years
in subcohort
Wild type K-ras Mutated K-ras
Number of cases RR (95% CI)a Number of cases RR (95% CI)a
Total alcohol (g/day)
No alcohol 6,761 96 1.00 56 1.00
!30.0 19,656 272 0.94 (0.7e1.2) 147 0.85 (0.6e1.2)
$30.0 2,624 49 1.25 (0.8e1.8) 28 1.13 (0.7e1.9)
Beerb
No beer 19,321 278 1.00 152 1.00
Beer drinker 9,722 139 0.84 (0.6e1.1) 79 0.86 (0.6e1.2)
Wineb
No wine 13,601 202 1.00 117 1.00
Wine drinker 15,441 215 0.92 (0.7e1.2) 114 0.88 (0.6e1.2)
Liquorb
No liquor 14,883 190 1.00 109 1.00
Liquor drinker 14,159 227 1.22 (0.9e1.6) 122 1.07 (0.8e1.5)
RR5 incidence risk ratio; CI5 confidence interval; CRC5 colorectal cancer.
aAdjusted for age, family history of CRC (yes/no), body mass index (kg/m2), calcium intake (mg/day), linoleic intake (g/day), and smoking (never/ex/
current).
bAdditionally adjusted for total alcohol consumption (0, !30.0, $30.0 g/day).
B.W.C. Bongaerts et al. / Ale.g., the induction of reactive oxygen species through the
induction of cytochrome P-450 2E (Badger et al., 2003;
Boffetta & Hashibe, 2006; Seitz et al., 2005). Many of these
processes have been observed in heavy or chronic alcohol
consumers. The amount of alcohol-related damage tends
to follow a doseeresponse relationship and as such, higher
levels of daily alcohol intakes may be needed for genetic
mutations to occur as a result of alcohol consumption.
Moderate consumption levels, as in our study population,
might not be able to increase CRC risk through causing
specific gene mutations. This may explain why we do not
observe a differential association between alcohol con-
sumption and K-ras and K-rasþ tumors. Thus, moderate
drinking apparently involves a certain risk of developing
colorectal tumors, possibly arising through mechanisms
other than those causative of genetic aberrations.
Liquor consumption as opposed to nonliquor consump-
tion, increased the risk of a K-ras rectal tumor in men in-
dependent of the alcohol consumed. Although this finding
was statistically significant, we must warrant caution not
to overinterpret this result. We performed many analyses
and therefore it is possible that this is merely a chance find-
ing. Moreover, the reference group was relatively small
compared to the number of liquor drinking K-ras rectal
cancer cases. Also, liquor was the most frequently con-
sumed beverage type among the male cancer cases and as
such, a statistically significant result is more likely to be
found for liquor than for beer or wine.
To date, some studies have been performed on the effect
of different lifestyle factors on genetic alterations of the
K-ras gene (Bautista et al., 1997; Martinez et al., 1999;
Slattery et al., 2000, 2001), of which only two considered
alcohol consumption (Martinez et al., 1999; Slattery
et al., 2000). Martinez et al. (1999), who conducted cross-
sectional analyses among adenoma patients in a phase III
trial, found no associations between total alcohol consump-
tion and K-ras gene mutations in adenomas. Slattery et al.
(2000), used data collected as part of a large population-
based caseecontrol study on sporadic colon cancer. With-
out distinguishing between men and women, the authors
found that levels of alcohol intake above 10 g/day reduced
the risk of K-rasmutations in colon tumors (odds ratio [OR]:
0.7, 95%CI: 0.5e1.0). None of the above mentioned authors
reported on the different types of alcoholic beverages.
4.2. Alcohol, CRC, and type of K-ras mutations
Our data showed no association between beer consump-
tion, independent from alcohol intake, and colon tumors
with a G/A mutation in men, whereas a statistically sig-
nificant increased risk was observed for rectal tumors with
a G/A mutation. Again, caution is warranted not to over-
interpret this result. The increased risk was based on merely
13 male rectal cancer cases with a G/A mutation and
a reference group of only 7 cases. As mentioned in Section
1, the adverse effects of elevated NDMA levels present inbeer before 1979 might influence the risk of cancer for
up to 10 years later. We checked the exact year of cancer
diagnosis of the 13 male rectal cancer cases that harbored
a G/A mutation; however, only one of these cases was
diagnosed between January 1979 and January 1990, namely
in 1989. Also, the results in Table 2, based on 22 male K-
rasþ rectal cancer cases and a reference group of 14 cases,
indicated that beer, independent of consumed alcohol, was
not associated with the risk of rectal tumors harboring a mu-
tated K-ras gene. Unfortunately, we have not been able to
gather information on the actual nitrosamine levels that were
present in beer over the past few decades, or on whether
these concentrations might vary across different types of
beer and brands. We therefore will not emphasize the asso-
ciation we observed between beer consumption in men
and rectal cancer harboring a G/A mutation too much.
To our knowledge, only one other study reported an
association between total alcohol consumption, but not
specific beverage types, and different types of K-ras muta-
tions (Slattery et al., 2000). In this study, the authors found
that levels of alcohol above 10 g/day were associated with
a reduced risk of G/A mutations in their population-
based caseecontrol study on sporadic colon cancer (OR:
0.7, 95% CI: 0.4e1.1).
4.3. Strengths and limitations of the study
This prospective study was based on a large population.
Due to record linkage to the NCR and to PALGA, losses to
follow-up were minimized. The high completeness of fol-
low-up of cancer incidence and of subcohort members also
minimized selection and information bias. Exclusion of
cases diagnosed during the first 2.3 years of follow-up,
diminished the chance of information bias due to preclini-
cal symptoms of CRC.
Our study is currently the largest prospective study that
has investigated associations between alcohol consumption
and colon and rectal cancer with and without K-ras muta-
tions. Nevertheless, it should be noted that the number of
colon and rectal cancer cases in certain subgroups are
small.
4.4. Conclusion
This study does not show a clear relationship between
alcohol consumption and risk of colon and rectal tumors
with a K-rasmutation, nor was a positive association appar-
ent between beer consumption and the risk of colon and
rectal tumors harboring G/A transitions in the K-ras
gene. Liquor consumption in men, seemed to be a potential
risk factor for developing a K-ras rectal tumor, indepen-
dent of the alcohol consumed. We conclude that although
daily alcohol consumption from a certain level of consump-
tion may be a risk factor for developing CRC, alcohol con-
sumption seems not involved in predisposing to CRC
through (specific) mutations in the K-ras gene.
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